Chemical Entities of Biological Interest
7495 terms(s) returned
| Term Type: | Record: 201 to 250 of 7495 Records | Page: 5 of 150, First Previous Next Last | Show Records Per Page |
- (14alpha,22E)-14-hydroxyergosta-7,22-diene-3,6-dione
- (15-Ethylidene-6-methoxy-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraen-13-yl)methanol
- (15:1)-Cardanol
- (15N)Ammonium (15N)thiocyanate
- (15R)-15-hydroxypalmitic acid
- (15S)-15-hydroperoxy-prostaglandin E2(1-)
- (15S,16Z,17S)-16-ethylidene-4-hydroxy-15-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,10,14,20-tetraoxatetracyclo[21.2.2.13,7.012,17]octacosa-1(25),3,5,7(28),12,23,26-heptaene-11,19-dione
- (15S,17S)-(-)-sclerodinol
- (15Z)-12-oxophyto-10,15-dienoate
- (15Z)-12-oxophyto-10,15-dienoic acid
- (15Z)-phycoviolobilin(2-)
- (15Z,18Z,21Z,24Z)-triacontatetraenoate
- (15Z,18Z,21Z,24Z,27Z)-triacontapentaenoate
- (15Z,18Z,21Z,24Z,27Z)-triacontapentaenoic acid
- (15alpha)-15-hydroxysoyasapogenol
- (16)(17)-methyloctadecanoic acid
- (16R)-16-hydroxymargaric acid
- (16R,17S)-8-(4-Morpholinyl)-17-[2-(4-morpholinyl)-2-oxoethyl]-12-oxa-1,4-diazatricyclo[14.3.1.06,11]icosa-6,8,10-trien-2-one
- (16R,19E)-isositsirikine
- (16R,19Z)-isositsirikine
- (16S*,18S*,19R*)-12,18-dihydroxy-19-methoxy-16,18-dimethyl-10-phenyl-[11]-cytochalasa-6(7),13(E)-diene-1,21-dione
- (16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoate
- (16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoic acid
- (16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoyl-CoA
- (16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoyl-CoA(4-)
- (16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoate
- (16alpha,20R)-20,24-epoxy-2,16-dihydroxy-25,26,27-trinorcucurbita-1,5,23-triene-3,11,22-trione 2-O-beta-Dglucopyranoside
- (16alpha,20R,22S,23S)-16,23:22,25-diepoxy-2,20,22,23-tetrahydroxycucurbita-1,5-diene-3,11-dione 2-O-beta-D-glucopyranoside
- (16alpha,20R,24R)-24N,25-carbamoyloxy-2,16,20-trihydroxycucurbita-1,5-diene-3,11,22-trione 2-O-beta-D-glucopyranoside
- (16alpha,20R,24S)-16,24-epoxy-2,20,25-trihydroxycucurbita-1,5-diene-3,11,22-trione 2-O-beta-D-glucopyranoside
- (16alpha,20R,24S)-2,16,20,25-tetrahydroxy-24-methoxycucurbita-1,5-diene-3,11,22-trione 2-O-beta-D-glucopyranoside
- (16alpha,20S,22S,23S)-16,23:22,25-diepoxy-2,22,23-trihydroxycucurbita-1,5-diene-3,11-dione 2-O-beta-D-glucopyranoside
- (17R)-17-methylincisterol
- (17Z)-3,11-dioxopregna-4,17(20)-dien-21-oic acid methyl ester
- (17Z)-hexacosenoate
- (17Z)-protosta-17(20),24-dien-3beta-ol
- (17Z,20Z,23Z,26Z)-dotriacontatetraenoate
- (17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoate
- (17beta,20R,22E,24R)-1-methyl-19-norergosta-1,3,5,7,9,14,22-heptaene
- (17beta,20R,22E,24R)-19-norergosta-1,3,5,7,9,14,22-heptaene
- (18)F radiopharmaceutical
- (18R)-18-hydroxynonadecanoic acid
- (18S )-18-O-a-L-rhamnopyranosyl-(1-4)-b-D-glucopyranosideto protoconstipatic acid
- (18S)-resolvin E2(1-)
- (18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoate
- (18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoic acid
- (18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoyl-CoA
- (18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoyl-CoA(4-)
- (18Z,21Z,24Z,27Z,30Z,33Z)-hexatriacontahexaenoate
- (19E)-cur-19-en-17-al(1+)
